Bon Natural Life Limited

BON

KYG144921130

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-17 EDT			5-day change	1st Jan Change
2.53 ^USD	-4.89%		-8.99%	-53.15%

04-19	Bon Natural Life Limited Appoints Liu Pijun as Co-Chairman and Member of Board of Directors	CI
02-09	Bon Natural Life Limited Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Bon Natural Life Limited Announces Appointment of Jing Chen and Zhixiang Gao as Additional Independent Directors

October 12, 2023 at 12:54 pm

Bon Natural Life Limited Announced Appointment OF Jing Chen and Zhixiang Gao as additional independent directors on October 2, 2023.

Latest news about Bon Natural Life Limited

Bon Natural Life Limited Appoints Liu Pijun as Co-Chairman and Member of Board of Directors	04-19	CI
Bon Natural Life Limited Reports Earnings Results for the Full Year Ended September 30, 2023	02-09	CI
Bon Natural Life Limited Announces $45 Million Broccoli Product Order with Beijing Huahai Keyuan	12-05	CI
Bon Natural Life Limited Announces Advancement in Sulforaphane	11-30	CI
Bon Natural Life Limited Announces Appointment of Jing Chen and Zhixiang Gao as Additional Independent Directors	23-10-12	CI
Bon Natural Life Limited Announces Signing Mou for Distributing Jiangwang Spirits in China	23-10-06	CI
Top Premarket Gainers	23-09-20	MT
Bon Natural Life Limited Reports Earnings Results for the Half Year Ended March 31, 2023	23-09-11	CI
Bon Natural Life Limited Changes to Board of Directors	23-08-04	CI
Bon Natural Life Limited Announces Resignation of Board Members	23-06-30	CI
Sector Update: Consumer Stocks Decline Pre-Bell Thursday	23-06-22	MT
Powell's Senate Testimony, Economic Data Anticipated Amid Lower Exchange-Traded Funds, Equity Futures Pre-Bell	23-06-22	MT
Bon Natural Life Receives Non-Compliance Notice From Nasdaq	23-06-22	MT
Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks	23-06-02	CI
Bon Natural Life Limited Announces CFO Changes	23-04-21	CI
Top Premarket Decliners	23-02-27	MT
Bon Natural Life Limited Reports Earnings Results for the Full Year Ended September 30, 2022	23-02-10	CI
Bon Natural Life Limited Provides Update on Its Expansion Project	22-09-30	CI
Bon Natural Life Limited Reports Earnings Results for the Half Year Ended March 31, 2022	22-08-01	CI
Bon Natural Life Limited Announces Board Changes	22-06-30	CI
Bon Natural Life Limited Introduces New Powder Drink for Anti-H. Pylori and Digestive Health	22-06-16	CI
Bon Natural Life Completes Building Construction of Yumen Plant	22-05-05	MT
Bon Natural Life Limited Advances Towards Near Term Production and Completes Building Construction of Yumen Plant	22-05-05	CI
Bon Natural Life Limited Adds New Multi-Functional Health Supplements to Product Line	22-04-21	CI
Top Premarket Gainers	22-02-03	MT

Chart Bon Natural Life Limited

Duration

Period

More charts

Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Companyâs products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BON NATURAL LIFE LIMITED	-53.15%	3.71M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals